| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/2012 | CN101632509B Medicinal treatment shoe |
| 01/11/2012 | CN101623325B Ziziphora clinopodioides Lam. total flavonoid extract and production method thereof and application thereof in cardiovascular drug |
| 01/11/2012 | CN101606915B Novel pharmaceutical formulations of modafinil |
| 01/11/2012 | CN101574410B Effective components of peony leaves as well as preparation method and application thereof |
| 01/11/2012 | CN101524421B Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
| 01/11/2012 | CN101492470B Synthesis of phosphocreatine disodium salt |
| 01/11/2012 | CN101468144B Chinese medicine compound preparation for treating ventricular premature beat |
| 01/11/2012 | CN101412687B Preparation of optically-active pure ibutilide fumarate |
| 01/11/2012 | CN101397327B Use of dihydro ginsenoside Rg2 |
| 01/11/2012 | CN101385793B High-purity extraction method of total flavone from cherokee rose and use thereof in preparing medicine for treating cardio-cerebrovascular disease |
| 01/11/2012 | CN101305009B 氮杂取代的螺环衍生物 Aza-substituted spiro derivatives of |
| 01/11/2012 | CN101229366B Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 01/11/2012 | CN101209976B Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor |
| 01/11/2012 | CN101190281B Prune tree extract and preparation method and application thereof |
| 01/11/2012 | CN101134106B Pharmaceutical composition containing human urine kininogenase for treating cerebral infarction |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093343 Nitric oxide-releasing diazeniumdiolated compounds |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093224 Antisense modulation of C-reactive protein expression |
| 01/10/2012 | US8093214 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 01/10/2012 | US8091801 Generation of therapeutic microfoam |
| 01/10/2012 | CA2536187C Pharmaceutical composition comprising a combination of metformin and a statin |
| 01/10/2012 | CA2503719C Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 01/10/2012 | CA2460141C Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/10/2012 | CA2354029C Gene therapy for cardiomyopathy |
| 01/05/2012 | WO2012003475A1 Statin therapy monitored by galectin- 3 measurement |
| 01/05/2012 | WO2012003452A2 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | WO2012003392A1 Fused heterocyclic compounds as ion channel modulators |
| 01/05/2012 | WO2012003387A1 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | WO2012003370A2 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | WO2012003220A1 Use of a2b adenosine receptor antagonists for treating pulmonary hypertension |
| 01/05/2012 | WO2012002919A1 Pharmaceutical formulations comprising atorvastatin and aspirin |
| 01/05/2012 | WO2012002539A1 Novel noncrystalline bosentan and process for preparation thereof |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012002464A1 ω3 FATTY ACID COMPOUND PREPARATION |
| 01/05/2012 | WO2012002328A1 Blood hdl level increasing agent or anti-arteriosclerotic agent |
| 01/05/2012 | WO2012000945A1 Substituted dicyanopyridines and use thereof |
| 01/05/2012 | WO2012000425A1 Use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction |
| 01/05/2012 | WO2012000409A1 Peptides with activity of inhibiting angiogenesis and uses thereof |
| 01/05/2012 | WO2012000377A1 Pharmaceutical composition comprising levocarnitine and dobesilate |
| 01/05/2012 | WO2012000212A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | WO2012000048A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 01/05/2012 | WO2011143360A8 Compositions, methods and systems for the synthesis and use of imaging agents |
| 01/05/2012 | WO2011141113A3 Combination of vitamin k and nicotinamide |
| 01/05/2012 | WO2011096665A3 Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2011075471A3 Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
| 01/05/2012 | WO2011045760A3 Micronized olmesartan medoxomil compositions |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | WO2010133377A8 Fat blends and uses thereof |
| 01/05/2012 | US20120005128 Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation |
| 01/05/2012 | US20120004720 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 01/05/2012 | US20120004315 Selective Estrogen Receptor Modulator |
| 01/05/2012 | US20120004313 Crystalline form vi of agomelatine, preparation method and application thereof |
| 01/05/2012 | US20120004312 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/05/2012 | US20120004310 Non-peptide bdnf neurotrophin mimetics |
| 01/05/2012 | US20120004307 Oral treatment of digital ischemic lesions |
| 01/05/2012 | US20120004297 Agent for alleviating vascular failure |
| 01/05/2012 | US20120004283 Novel shrna gene therapy for treatment of ischemic heart disease |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004267 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004261 Mif modulators |
| 01/05/2012 | US20120004256 Parenteral formulation of clopidogrel |
| 01/05/2012 | US20120004253 Novel Fused Pyrrolocarbazoles |
| 01/05/2012 | US20120004252 New ccr2 receptor antagonists and uses thereof |
| 01/05/2012 | US20120004248 Methods of using a methylxanthine compound |
| 01/05/2012 | US20120004246 Purinyl derivatives and their use as potassium channel modulators |
| 01/05/2012 | US20120004245 Compounds for the treatment of posterior segment disorders and diseases |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004243 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004232 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 01/05/2012 | US20120004222 Cb2 receptor ligands for the treatment of pain |
| 01/05/2012 | US20120004220 Selective androgen receptor modulators (sarms) and uses thereof |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 01/05/2012 | US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/05/2012 | US20120004203 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 01/05/2012 | US20120004200 Topical pharmaceutical composition containing a water-sensitive active principle |
| 01/05/2012 | US20120004198 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 01/05/2012 | US20120004188 Use of ranolazine for treating pulmonary hypertension |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004177 Compositions and methods of delivery of pharmacological agents |
| 01/05/2012 | US20120004171 Novel therapies for chronic renal failure |
| 01/05/2012 | US20120004164 Organic compounds |
| 01/05/2012 | US20120003629 Biological control of nanoparticle nucleation, shape and crystal phase |
| 01/05/2012 | US20120003329 Use of A2B Adenosine Receptor Antagonists for Treating Pulmonary Hypertension |
| 01/05/2012 | US20120003318 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |